Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 3
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Genetic and Molecular Basis of Heterogeneous NK Cell Responses against Acute Leukemia.
Makanga DR, Da Rin de Lorenzo F, David G, Willem C, Dubreuil L, Legrand N, Guillaume T, Peterlin P, Lebourgeois A, Béné MC, Garnier A, Chevallier P, Gendzekhadze K, Cesbron A, Gagne K, Clemenceau B, Retière C. Makanga DR, et al. Cancers (Basel). 2020 Jul 16;12(7):1927. doi: 10.3390/cancers12071927. Cancers (Basel). 2020. PMID: 32708751 Free PMC article.
Posttransplant Cyclophosphamide and Antithymocyte Globulin versus Posttransplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis for Peripheral Blood Stem Cell Haploidentical Transplants: Comparison of T Cell and NK Effector Reconstitution.
Makanga DR, Guillaume T, Willem C, Legrand N, Gagne K, Cesbron A, Gendzekhadze K, Peterlin P, Garnier A, Le Bourgeois A, Béné MC, Chevallier P, Retière C. Makanga DR, et al. J Immunol. 2020 Sep 1;205(5):1441-1448. doi: 10.4049/jimmunol.2000578. Epub 2020 Aug 3. J Immunol. 2020. PMID: 32747504
Impact of KIR/HLA Incompatibilities on NK Cell Reconstitution and Clinical Outcome after T Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation with Posttransplant Cyclophosphamide.
Willem C, Makanga DR, Guillaume T, Maniangou B, Legrand N, Gagne K, Peterlin P, Garnier A, Béné MC, Cesbron A, Le Bourgeois A, Chevallier P, Retière C. Willem C, et al. Among authors: makanga dr. J Immunol. 2019 Apr 1;202(7):2141-2152. doi: 10.4049/jimmunol.1801489. Epub 2019 Feb 20. J Immunol. 2019. PMID: 30787107
Centromeric KIR AA Individuals Harbor Particular KIR Alleles Conferring Beneficial NK Cell Features with Implications in Haplo-Identical Hematopoietic Stem Cell Transplantation.
Dubreuil L, Maniangou B, Chevallier P, Quéméner A, Legrand N, Béné MC, Willem C, David G, Alizadeh M, Makanga DR, Cesbron A, Gendzekhadze K, Gagne K, Retière C. Dubreuil L, et al. Among authors: makanga dr. Cancers (Basel). 2020 Dec 1;12(12):3595. doi: 10.3390/cancers12123595. Cancers (Basel). 2020. PMID: 33271841 Free PMC article.